Today: 16 May 2026
Browse Category

Earnings Reports 28 January 2026

Stride (LRN) stock jumps 26% premarket after earnings and outlook; what to watch at the open

Stride (LRN) stock jumps 26% premarket after earnings and outlook; what to watch at the open

Stride shares soared 26% to $91.50 in premarket trading Wednesday after reporting a 7.5% revenue gain to $631.3 million for the December quarter and raising its full-year outlook. Career Learning revenue jumped nearly 29%, with total enrollments up 7.8% to 248,500. The company announced a $500 million stock buyback program through October 2026. BMO Capital raised its price target to $94.
S&P 500 futures edge up before Fed decision as Texas Instruments pops on AI data-center demand

S&P 500 futures edge up before Fed decision as Texas Instruments pops on AI data-center demand

S&P 500 futures rose 0.32% and Nasdaq 100 futures gained 0.72% early Wednesday ahead of the Federal Reserve’s policy decision and major tech earnings. Texas Instruments jumped about 9% premarket after strong AI-driven results, while Seagate Technology climbed on robust cloud demand. The S&P 500 closed Tuesday at 6,978.60, up 0.41%. Investors remain focused on Fed signals for rate cuts later this year.
Dow Jones today: Dow futures inch up as Fed decision and Big Tech earnings loom

Dow Jones today: Dow futures inch up as Fed decision and Big Tech earnings loom

Dow futures rose about 30 points ahead of the Fed’s policy decision, with S&P 500 and Nasdaq 100 futures also up. Health insurers slumped after U.S. officials proposed a 0.09% Medicare Advantage payment hike, far below expectations. The Dow fell 409 points Tuesday, dragged by UnitedHealth, Humana, and CVS losses, while the S&P 500 and Nasdaq hit records on tech gains. Microsoft and Meta will report earnings Wednesday.
AI stocks are moving before the bell: Nvidia rises as Microsoft, Meta earnings loom

AI stocks are moving before the bell: Nvidia rises as Microsoft, Meta earnings loom

Nvidia rose 1.7% and Intel jumped 6.6% in premarket trading Wednesday, leading gains among chip stocks. Microsoft and Meta are set to report earnings after the bell, with investors focused on AI spending and margins. ASML raised its 2026 sales forecast after strong bookings but announced 1,700 job cuts. SK Hynix posted record quarterly profit on surging demand for AI server memory.
IREN Limited stock price hovers near $60 premarket after 15% jump; earnings ahead

IREN Limited stock price hovers near $60 premarket after 15% jump; earnings ahead

IREN Limited shares rose 0.4% to $60.24 in premarket trading Wednesday after surging 14.6% the previous day on heavy volume. The company recently secured a $9.7 billion deal with Microsoft to supply Nvidia-based cloud capacity, with deployments set for its Texas campus through 2026. IREN will report quarterly results on Feb. 5. The stock remains volatile amid rising bitcoin prices and AI infrastructure investments.
Seagate stock jumps in premarket after earnings beat and upbeat outlook on AI storage demand

Seagate stock jumps in premarket after earnings beat and upbeat outlook on AI storage demand

Seagate shares jumped 11.6% in premarket trading Wednesday after the company reported fiscal second-quarter revenue of $2.83 billion and non-GAAP EPS of $3.11, both above estimates. The company forecast third-quarter revenue of $2.90 billion, beating consensus. Seagate will pay a $0.74 dividend on April 8 to shareholders of record March 25. The stock closed Tuesday at $407.97, up nearly 10%.
American Airlines stock price steadies in premarket after 7% drop on earnings, storm hit

American Airlines stock price steadies in premarket after 7% drop on earnings, storm hit

American Airlines traded near $13.55 in premarket Wednesday after a 7% drop Tuesday, triggered by a quarterly profit miss and over 9,000 cancellations from Winter Storm Fern. CFO Devon May called the storm’s impact the worst in company history. The airline expects a first-quarter adjusted loss and lower flying capacity. Investors await the April 23 earnings report for updates on recovery and cost pressures.
Lam Research stock price pops in premarket as LRCX heads into earnings

Lam Research stock price pops in premarket as LRCX heads into earnings

Lam Research shares rose 4.4% premarket Wednesday to $249, extending a rally ahead of its December-quarter earnings due after the U.S. close. The stock jumped 7% Tuesday after Evercore ISI and Lynx Equity raised price targets. Analysts expect revenue to reach $5.25 billion, up 20% year-over-year, with adjusted earnings at $1.17 per share. Investors are watching for updates on customer spending and service revenue.
Texas Instruments stock price jumps in premarket after forecast tops estimates — what to watch at the open

Texas Instruments stock price jumps in premarket after forecast tops estimates — what to watch at the open

Texas Instruments shares surged 7.5% to $211.30 in premarket trading after the company projected first-quarter revenue and earnings above forecasts. The chipmaker cited strong AI-driven data-center demand and a rebound in industrial markets. Fourth-quarter revenue reached $4.42 billion with earnings per share of $1.27, just below analyst estimates. Data-center revenue jumped 70% year-on-year in the December quarter.
Corning stock pops again on Meta’s $6B fiber deal as earnings hit before the bell

Corning stock pops again on Meta’s $6B fiber deal as earnings hit before the bell

Corning shares rose about 6% premarket after a $6 billion fiber-optic supply deal with Meta Platforms, following a 15.6% surge Tuesday. Corning will report fourth-quarter results at 8:30 a.m. ET, while Meta’s earnings are due after the close. Investors seek details on margins, spending, and the timeline for the Meta contract. The deal includes expanded manufacturing in North Carolina through 2030.
GSK share price slips in London as Arexvy EU expansion sinks in; earnings next week in focus

GSK share price slips in London as Arexvy EU expansion sinks in; earnings next week in focus

GSK shares dropped 1.8% to 1,828.5 pence by mid-morning Wednesday in London, reversing gains from earlier in the week. The decline followed news that the European Commission expanded approval of GSK’s RSV vaccine Arexvy to all adults 18 and older. Pfizer also secured similar approval for its RSV shot. Investors await guidance from European health agencies and GSK’s earnings report on February 4.
Unilever share price slips in early London trade as investors line up February results

Unilever share price slips in early London trade as investors line up February results

Unilever shares slipped 0.7% to 4,831.5 pence in early London trading, underperforming the FTSE 100’s 0.1% drop. Investors await Unilever’s full-year results on Feb. 12, focusing on volume growth and margins after the company spun off its Magnum unit and consolidated shares. European stocks paused after a two-day rally, with attention shifting to the U.S. Fed decision later today.
Yangzijiang Shipbuilding stock edges up to S$3.33 as Singapore STI dips — traders eye Fed, March earnings

Yangzijiang Shipbuilding stock edges up to S$3.33 as Singapore STI dips — traders eye Fed, March earnings

Yangzijiang Shipbuilding shares rose 0.3% to S$3.33 in afternoon trading Wednesday, rebounding after a late-January dip but still 11% below their Jan. 14 high. Short selling made up 43% of Tuesday’s 20.3 million shares traded. Singapore’s Straits Times Index slipped 0.47% after a 1.28% gain Tuesday. Yangzijiang’s next earnings release is scheduled for March 4.
Woodside Energy share price jumps after Q4 report, but 2026 output dip keeps traders cautious

Woodside Energy share price jumps after Q4 report, but 2026 output dip keeps traders cautious

Woodside Energy shares rose 2.7% to A$24.98 after its fourth-quarter update, despite forecasting lower 2026 output due to scheduled downtime at Pluto LNG. December-quarter revenue fell to $3.035 billion from $3.484 billion a year earlier. Scarborough project is 94% complete, with first LNG cargo expected in late 2026. Investors await the annual report briefing on Feb. 24.
Why Gilead stock hit a fresh 52-week high as Medicare targets Biktarvy and earnings loom

Why Gilead stock hit a fresh 52-week high as Medicare targets Biktarvy and earnings loom

Gilead Sciences shares rose 2.3% to $140.97 Tuesday, hitting a 52-week high after Medicare named its HIV drug Biktarvy for price negotiations starting in 2028. Trading volume topped 10.5 million shares. CEO Daniel O’Day sold 115,640 shares last week under a pre-set plan. Gilead will report fourth-quarter and full-year results after markets close on Feb. 10.
HCA stock jumps after earnings and a $10B buyback — what to watch before Wednesday’s open

HCA stock jumps after earnings and a $10B buyback — what to watch before Wednesday’s open

HCA Healthcare shares surged 7.1% to $505.84 after the company raised its 2026 profit outlook and approved a new $10 billion share buyback. Fourth-quarter revenue rose 6.7% to $19.51 billion, with net income at $1.88 billion. Investors remain cautious as ACA exchange subsidies expire, potentially reducing patient volumes. The board also declared a $0.78 quarterly dividend, payable March 31.
Starbucks stock dips as supply-chain snags and CEO jet policy land ahead of earnings

Starbucks stock dips as supply-chain snags and CEO jet policy land ahead of earnings

Starbucks shares fell 0.6% to $95.72 Tuesday ahead of its fiscal first-quarter earnings report set for Wednesday morning. CEO Brian Niccol is under scrutiny as supply-chain issues persist despite new technology and system upgrades. The company also removed the $250,000 cap on Niccol’s personal use of the corporate jet after a security review. Wall Street analysts adjusted price targets as investors focus on sales and margins.
1 87 88 89 90 91 248

Stock Market Today

  • Gratifii Insiders Recover Some Losses After AU$2.99m Share Purchase
    May 15, 2026, 9:32 PM EDT. Gratifii Limited (ASX:GTI) insiders made a AU$2.99 million share purchase over the last year, primarily by William Paterson who acquired 33.71 million shares at an average price of AU$0.089 each. Despite initial losses totalling AU$1.2 million, recent stock gains of 11% over one week have partially recovered those losses. Insiders hold 24% ownership valued at AU$5.5 million, indicating solid alignment with shareholders. No insider trading took place in the last quarter, but overall activity suggests confidence in the company. The insider purchase above current prices (AU$0.052) typically signals a bullish view. Observers note that insider transactions, while not sole investment indicators, are important for assessing executive confidence in a stock.

Latest articles

Dow Drops 537 Points With After-Hours Selling Threatening Wall Street AI Rally

Dow Drops 537 Points With After-Hours Selling Threatening Wall Street AI Rally

16 May 2026
U.S. stock ETFs fell in after-hours trading Friday following a more than 1% drop in the S&P 500, Dow, and Nasdaq. Oil surged 4.2% to $105.42 a barrel and the 10-year Treasury yield hit 4.597%, fueling concerns over inflation and Fed rate hikes. Nvidia, AMD, and Intel led chip declines, while Berkshire Hathaway disclosed a $2.65 billion Delta stake and exited Amazon, Visa, and Mastercard.
Accuray inks 10-year cancer tech agreement, shares in focus

Accuray inks 10-year cancer tech agreement, shares in focus

16 May 2026
Accuray and the University of Wisconsin School of Medicine and Public Health signed a 10-year research agreement focused on Accuray’s Stellar adaptive radiotherapy platform. The announcement came after market close, with Accuray shares ending down 5.2% at $0.27. The deal follows Accuray’s recent withdrawal of fiscal 2026 guidance and ongoing financial pressures.
Origin Materials Gains as Filing Signals $3.54 Liquidation Payout Possible

Origin Materials Gains as Filing Signals $3.54 Liquidation Payout Possible

16 May 2026
Origin Materials asked shareholders to approve a plan to liquidate and dissolve the company, estimating an initial payout of $0.61 to $3.54 per share depending on asset sales and claims. Shares rose 15% to $1.43 after the filing. The company reported a 91% drop in first-quarter revenue and warned it may not survive without the wind-down. Origin cut 59% of its workforce and CEO John Bissell stepped down May 1.
NextNRG Q1 Revenue Gains, but Company Holds Cash Warning

NextNRG Q1 Revenue Gains, but Company Holds Cash Warning

16 May 2026
NextNRG reported first-quarter revenue of $21.1 million, up 29% from a year earlier, but its net loss widened to $10.8 million. Cash fell to $208,048 at quarter-end, and management warned it needs immediate capital to continue operations. Shares closed at $0.2804 on Nasdaq, down nearly 6%. Total liabilities reached $34.3 million, with a stockholders’ deficit of $22 million.
Go toTop